All In MedTech

Device Trial Radar · NCT01712087

Long-term Surveillance of the MedStream Programmable Infusion System

Long-term Surveillance of the MedStream Programmable Infusion System for the Intrathecal Infusion of Baclofen in the Treatment of Spasticity

Last checked: Nov 20, 2026Latest source record: Jan 23, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

2

Actual

Start

Oct 1, 2012

Primary completion

Dec 17, 2017

Study completion Dec 17, 2017

Sponsor

Lead sponsor
Codman & ShurtleffNot on our public-company list
Sponsor type
Industry
First posted
Oct 23, 2012

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This post-approval study will primarily evaluate the long-term safety of the MedStream Programmable Infusion System when used in combination with Baclofen for the treatment of severe spasticity. A secondary objective, to assess long-term effectiveness, based on the observed scores on the Ashworth Scale (rigidity for the lower extremities) and their Spasm Scores over the 36-month follow-up period will also be described.

Conditions

  • Spasticity

Interventions

  • MedStream Programmable Infusion SystemDevice

    Intrathecal Infusion of Baclofen in the Treatment of Spasticity

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary endpoint is the incidence of MedStream system-related Adverse Events (AE)Time frame: 24 Months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • UMass Memorial Medical Center

    Worcester, Massachusetts

  • Methodist Hospital Research Institute

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.